icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
RO7049389, a core protein allosteric modulator, demonstrates robust decline in HBV DNA and HBV RNA in chronic HBV infected patients
 
 
  EASL 2019 Vienna April
 
Man-Fung Yuen1, Christian Schwabe2,TawesakTanwandee3,, YuyanJin4, Lu Gao4, XueZhou4, SudipDas5,Yifan Wang4, Annabelle Lemenuel-Diot6, Valerie Cosson6, Sheng Feng4, Dominik Meinel6, MingfenZhu4, QingyanBo4, Edward Gane7 1 The University of Hong Kong, Hong Kong, China; 2.Auckland Clinical Studies, Auckland, New Zealand; 3 MahidolUniversity, Bangkok, Thailand; 4 Roche Innovation Centre Shanghai, Shanghai, China; 5 Roche Products Limited, Shire Park, United Kingdom; 6 Roche Innovation Centre Basel, Basel, Switzerland; 7 The University of Auckland, Auckland, New Zealand

0612191

0612192

0612193

0612194

0612195

0612196

0612197

0612198